Members

Align Biopharma's leading biopharma, technology, and service providers aim to develop and support the adoption of open technology standards that make it easier for healthcare professionals (HCPs) to work with life sciences. Align Biopharma leadership sets the group's priorities, dedicates expert resources to standards initiatives, and contributes to the review and authoring of standards.

Life Sciences
Allergan AstraZeneca Bayer
Biogen GSK Janssen Lilly
Merck KGaA Darmstadt, Germany
Merck & Co., Inc. Novartis
Pfizer Shire Takeda
Technology
Adobe Exostar Gygia
Janrain Okta Veeva
Services
Accenture Cognizant
Deloitte Mavens
ALLERGAN

Patrick Retif
Vice President, IT, Global Commercial
Steve Furnari
Executive Director, Commercial IT
ASTRAZENECA

Matt Pammer
Vice President, IT, International & Europe
Mike Manis
Senior Director, Global Commercial IT
BIOGEN

Scott Cenci
Vice President, Global Therapeutic Operations IT
Claude Lutringer
Head IT international
GLAXOSMITHKLINE

Tom Flores
Vice President, Global Commercial Services & Pharma IT
Maryka Petris
IT Business Process Partner, Sales Excellence
LILLY

Jennifer Oleksiw
Vice President & Information Officer
Phil Bartlett
Senior Director, IT Oncology & Global BU Hosting Services
MERCK & CO., INC.

Phyllis Post
Vice President & CIO, Global Human Health, IT
Frank Millheim
Lead Architect, Global Human Health, IT
NOVARTIS

Andreas Mueller
Global Head, Pharma IT & Commercial IT
PFIZER

Dennis Hancock
Vice President, Global Commercial Solutions
Hank Pellegrino
Global Sales and Commercial Operations Solutions Lead
TAKEDA

Manfred Reuters
Vice President IT
Peter Schnack
Senior Director and Global Head of Commercial and Marketing Systems
VEEVA

Henry Levy
President, Align Biopharma and Chief Strategy Officer, Veeva
Arno Sosna
Chief Technology Officer, Align Biopharma and General Manager, Veeva CRM

ALLERGAN
Patrick Retif
Vice President, IT, Global Commercial

Patrick is the vice president of IT global commercial at Allergan, where he has enhanced customer engagement by deploying Veeva to 8,000 reps in 52 countries, innovated in social media technologies, and enabled digital capabilities by implementing a digital factory platform supporting over 450 websites.

Patrick has successfully supported over 15 product launches in two years, completed the largest 2015 M&A integration of Allergan commercial IT, and led over a dozen of various integrations and divestitures that included redesigning IT organizations and harmonizing hundreds of systems.

Patrick has more than 25 years experience as a business-focused IT executive, ensuring IT excellence through constant M&A activities and transforming commercial IT departments.

Prior to Allergan, Patrick worked at Forest Laboratories as the vice president of IT commercial, where he modernized the commercial organization’s IT infrastructure and processes that revolutionized time to market and provided high flexibility and change capability to the business.

Patrick has also held executive IT leadership roles at IMS Health, HighPoint Solutions, CSC, PwC, and Dendrite.


ALLERGAN
Steve Furnari
Executive Director, Commercial IT

Steve is executive director, global commercial IT at Allergan, where he is responsible for the business relationship with U.S. marketing organizations and the global marketing center of excellence for digital factory and platforms supporting more than 450 websites, mobile applications, multichannel digital assets, Veeva Vault, and Adobe solutions.

Steve has more than 25 years of business experience delivering innovative commercial solutions and services in the pharmaceutical, medical device, and consumer industries. In these roles, he has led global organizations, M&A integration and divestiture programs, numerous product launches, and technology strategy, delivery, and operations across global business functions.

Steve has also held corporate and consulting leadership positions at Johnson & Johnson, Schering-Plough, Novartis, Glemser Technologies, and Dendrite.


ASTRAZENECA
Matt Pammer
Vice President, IT, International & Europe

Matt is vice president of commercial IT at AstraZeneca, where he is responsible for creating and executing the IT vision, strategy, and operational plan for the global commercial business and the regional marketing companies. His priorities include transforming selling capabilities to address specialty care portfolios, extending reach and impact of digital channels, improving access to information to gain unique insights and a competitive advantage, simplifying the IT application landscape, and driving commercial innovation. Over the last three years, Matt has led the transformation of the commercial IT team to deliver twice the value for half the cost by internalizing technical skills, adopting global and mobile commercial platforms, eliminating legacy applications, and adopting cloud applications.

Matt has more than 25 years life science experience in IT across commercial functions, including customer relationship management, reporting and analytics, and marketing. Matt joined AstraZeneca in 1994. He led the North American team in building commercial capabilities and he established the architecture function.

Prior to AstraZeneca, Matt worked at Accenture in the advanced systems group, where he consulted across several industries including banking, insurance, healthcare, and pharmaceutical. Matt holds a bachelor of science degree in computer science from Albright College and an MBA from Temple University.


ASTRAZENECA
Michael Manis
Senior Director, Global Commercial IT

Michael is the senior director of global commercial IT at AstraZeneca, where he is responsible for the solution delivery center for AstraZeneca’s global commercial organization, application delivery, and the center of excellence for Salesforce.com, Veeva, and Adobe platforms.

Michael has more than 30 years of experience delivering customer facing systems and services in the pharmaceutical, travel, transportation, gaming and retail industries. In these roles he led a global infrastructure organization, an enterprise application delivery organization, and deployed the industry’s first CRM solutions.

Prior to AstraZeneca, Michael worked at Medimmune, where he was the senior director of information systems infrastructure, responsible for all information system data centers, global engineering, and support of enterprise and end-user services.

Michael has also held IT leadership positions at Office Depot, Alamo National Rental Car, Harrah’s Casino, and Holiday Inns/Promus Hotels.


BIOGEN
Scott Cenci
Vice President, Global Therapeutic Operations

Scott is the vice president, global therapeutic operations IT at Biogen, where he is responsible for global IT strategy and execution across sales, marketing, and patient services, as well as IT program management and delivery for the following solutions: CRM, CMS, mobile, and web.

Scott has more than 25 years of life science IT experience across commercial, medical, development, and genetics business domains as well as core IT functions of infrastructure, business analysis, service and solution delivery. His proven track record of helping to shape the technology landscape for his customers, and his experience with both human and animal health businesses provides him with a unique perspective on customer engagement in life sciences.

Prior to Biogen, Scott worked at Zoetis, where he was the head of the US commercial and global businesses technology group and served as a key member of the US operations leadership team in driving a successful IPO and transformation into the leading global animal health company.

Scott also held IT roles of increased responsibility at Pfizer, Novartis, and Ciba Pharmaceuticals.


BIOGEN
Claude Lutringer
Head IT international

Claude is the head of Biogen’s international IT organization for Europe, APAC, and LATAM where he is responsible for ensuring IT activities, budgets, and portfolios are strategically and operationally aligned with global business and IT needs.

Claude has more than 20 years IT experience in the pharmaceutical industry, specializing in commercial operations, supply chain planning optimization, and implementing global enterprise management solutions.

Prior to Biogen, Claude held various vice president positions at Roche Pharma, where he was the regional chief information officer for CEMAI (Middle east, central Asia, India subcontinent and Africa) from 2006 to 2013 and global head of SAP and Ariba from 2002 to 2006.


GLAXOSMITHKLINE
Maryka Petris
IT Business Process Partner, Sales Excellence

Maryka is the IT business process partner, sales excellence, at GSK, where she is responsible for strategy definition for sales excellence solutions in consumer healthcare, project delivery, and ongoing support of all global sales solutions.

Maryka has more than 15 years of experience in the pharmaceutical industry, joining GSK in 2002 as a business analyst for the IT sales and marketing team in the UK. Since then she successfully delivered ERP, business intelligence, financial planning, and Salesforce automation solutions to GSK consumer healthcare, managed trade promotion and call centers, and supported global system integration projects.

Prior to joining GSK, Maryka worked as business intelligence consultant for a number of companies in Europe and as a system owner for the Italian Stock Exchange.


LILLY
Jennifer Oleksiw
Vice President and Information Officer, Pharma Business Units

Jennifer is the vice president and information officer for the Lilly pharma business units, where she is responsible for providing strategic partnership to Lilly bio-medicines, Lilly international, diabetes, and oncology business units as well as the centralized marketing organization and global medical affairs to ensure delivery of business value through technology solutions.

Jennifer joined Lilly in 2000 from Ernst & Young and has held various leadership positions in global services IT, manufacturing IT and research and development IT organizations. In her previous assignment in manufacturing IT, she was responsible for developing and executing the IT strategy for the dry product, parenteral, device, and distribution sites. In this role, she also had responsibilities for the data integration and document management teams as well as the manufacturing execution system implementations. Prior to that, her responsibilities included the development and launch of IT solutions for integrative informatics, combined specimen banking, drug metabolizing enzymes and transporters (DMET) and gene assay management.

Jennifer has also served in various application engineer and leadership roles across multiple releases of Lilly’s global SAP implementation. Jennifer received a bachelor of science degree in business from Indiana University and a master’s degree in business administration from the Kellogg School of Management at Northwestern University.


LILLY
Phil Bartlett
IT Senior Director, Oncology Business Unit

Phil is the IT senior director for Lilly’s global oncology business unit. He is also accountable for enabling Lilly’s business strategy through technical capabilities across all business units and geographies. These capabilities support Lilly’s sales, marketing, medical affairs, commercial master data, commercial analytics and real world evidence organizations.

Phil joined Lilly in 1999 and has held various leadership positions in Lilly’s global services IT and enterprise IT organizations. In global services IT, Phil led many SAP ERP implementations in various countries that reengineered business processes for customer service, logistics, distribution, serialization, manufacturing finance and intercompany processing. In enterprise IT, Phil created the global shared services organization that delivered business intelligence and advanced analytics technologies and services for the company.

Phil received a bachelor of science in industrial management from Purdue University.


MERCK & CO., INC.
Phyllis Post
Vice President & CIO, Global Human Health, IT

Phyllis is the global head of IT for Merck & Co., Inc.’s Commercial division, where she is responsible for enabling business value through strategic partnerships, and implementing and orchestrating the delivery of priority capabilities and user-oriented solutions. This includes value add and innovative solutions to help the company meet its customer, revenue and productivity goals as well as Commercial and Patient solutions.

Since joining the Company in 1998, Phyllis has also held IT leadership positions supporting Merck & Co., Inc.’s Global Research Laboratories and the corporate enterprise division. Most recently, as the Asia Pacific client services and IT regional center leader, Phyllis provided regional leadership for both the IT innovation & development center and the IT business partnerships for commercial, manufacturing and R&D divisions.

Prior to joining Merck & Co., Inc., Phyllis worked for a variety of mid-tier typesetting and web development companies that were engaged primarily in the publication of financial, scientific, medical and technical materials. Additionally, Phyllis served as a board member for the Typesetters Association of NY and as President for PrintNJ.

Phyllis holds an MBA in technology management from the University of Phoenix, as well as a B.A. from Douglass College.


MERCK & CO., INC.
Frank Millheim
Lead Architect, Global Human Health, IT

Frank is the lead architect for commercial technology platforms at Merck & Co., Inc., covering digital marketing, customer engagement, and customer information management. Frank leads the creation and realization of technology strategy for Merck & Co., Inc.ʼs global commercial business, focusing on driving value through flexible, elastic, reliable, and effective solutions.

Frank has over 20 years life science experience spanning sales operations, customer experience management, digital marketing, mobility and analytics. Joining Merck & Co., Inc. in 1999, Frank focused on supporting sales operations and mobility in the US market. His role has grown over time to address systems across multiple disciplines within the commercial space as well as across the globe. An early advocate of what is now called cloud computing, Frank has been instrumental in modernizing Merck & Co., Inc.ʼs existing capabilities as well as driving new innovation.

Prior to joining Merck & Co., Inc., Frank held various IT positions at various companies focused on life sciences, financial accounting, and hospitality.


PFIZER
Dennis Hancock
Vice President, Global Commercial Solutions

Dennis is the vice president of global commercial solutions organization for Pfizer and is responsible for strategy and execution across three centers of excellence: mobile and emerging technologies, digital marketing, and sales enablement.

Dennis and his teams have received a number of recent awards, including a 2017 Digital Edge 50 award, InformationWeek’s Elite 100, a CIO 100 award for innovation, and consistent accolades for execution in the areas of digital, mobile, and embracing SaaS and cloud solutions at an enterprise level resulting in annual savings to Pfizer.

In the last year, Dennis’s organization created more than 100 mHealth apps for patients and HCPs, more than 600 external facing digital assets globally, executed more than 7,000 campaign changes across these properties, and made major advancements in leveraging cognitive computing to improve field force effectiveness and impact.

In addition to his work at Pfizer, Dennis is also on the board of the Philadelphia Alliance for Capital and Technologies (PACT).


PFIZER
Hank Pellegrino
Global Sales and Commercial Operations Solutions Lead

Hank is the global sales and commercial operations solutions lead at Pfizer, where he is responsible for managing the technology investments to empower Pfizer’s global sales organization. His top priorities include maintaining the strategic roadmap, execution of the programs to realize the business value outlined in the plan, and providing support operations to the global portfolio of assets.

Hank has led several complex global programs to drive process harmonization and technology standardization across the commercial organization at Pfizer. These programs included replacing a disparate set of antiquated sales force automation tools with a cloud based global solution which is now centrally managed adding business value through continuous innovation and a cost effective support model. He also led a team to implement one of the largest global promotional material review and approval solutions in the industry.

Prior to his current role Hank was the marketing and sales solutions center lead for the Pfizer diversified business units. In this role he was responsible for leading technology strategy, delivery, and operations across commercial operations. He played a key role in defining the digital marketing strategy for Pfizer which included implementing an open source framework to increase agility and drive efficiency.

Earlier in his career Hank was a member the Pfizer consumer healthcare international leadership team where he was responsible for partnering with country general managers to identify and deliver key process and technology changes required to support rapid international growth. He developed a strong understanding of the global commercial business and was able to successfully drive process harmonization changes across global markets which increased business value through the use of technology.

Hank earned bachelor of science in accounting, MBA in finance, MS in computer science, and is a licensed CPA in the state of New Jersey. He is a member of both the New Jersey Society of Information Management and the American Institute of CPAs.


TAKEDA
Manfred Reuters
Vice President IT

Manfred is vice president of IT at Takeda, where he is responsible for all global commercial, sales, finance and procurement systems. Manfred is also the responsible CIO for the following areas: Russia / CIS, Europe, NEMEA (Near East, Middle East and Africa) and LATAM (Latin America).

Manfred has more than 28 years of experience in IT, 25 of these within the pharmaceutical industry. One of Manfred’s first projects was to equip the sales representatives with their first CRM system and laptop. Since the successful delivery of this project, Manfred has developed a passion for delivering innovative IT solutions to the commercial user community.

During his career Manfred has led various global IS/IT programs in the mergers and acquisitions (M&A) arena and was responsible for the implementation of a shared service centre for IT with full and transparent cost allocation.


TAKEDA
Peter Schnack
Senior Director and Global Head of Commercial and Marketing Systems

Peter is a senior director and global head of commercial and marketing systems at Takeda. He is responsible for driving CRM and customer engagement projects, application delivery, and business advisory services for all six business units at Takeda.

His main focus area is to enable the commercial transformation of Takeda by providing best-in-class building blocks supporting the customer engagement strategy in an efficient and scalable way and facilitating internal collaboration and digital innovation leveraging new channels and insights. As a key part of this, Peter and his organization are leading several programs to deploy global cloud-based CRM solution across countries in Europe, Canada, Japan, Latin America, and Greater China.

Peter has 15 years of experience with Commercial IT in the life sciences industry. Prior to joining Takeda, he was an IT management consultant within both the commercial and R&D space. He holds a Master of Science in Business Administration and Computer Science from Copenhagen Business School.


VEEVA
Henry Levy
President, Align Biopharma and Chief Strategy Officer, Veeva

Levy has nearly 25 years of experience transforming the way the biopharmaceutical industry improves patient health. He currently serves as chief strategy officer at Veeva Systems where he represents the company in various industry collaborations. Previously, he was chief commercial officer at PPD, one of the world’s largest CROs, and head of Accenture’s global life sciences R&D practice.

As president for Align Biopharma, Henry is responsible for working with members to define the strategy and focus for the group’s initiatives.


VEEVA
Arno Sosna
Chief Technology Officer, Align Biopharma and General Manager, Veeva CRM

As chief technology officer for Align Biopharma, Arno is responsible for ensuring high quality technology standards that the industry can easily adopt and translate into practical solutions.

As general manager of Veeva CRM, Arno is responsible for the definition and direction of all Veeva CRM products globally, ensuring that Veeva delivers best-in-class solutions with a focus on streamlined usability, rich functionality, and end-to-end customer success.

Arno has extensive experience as a product manager and system architect of global CRM systems, and a background in life sciences that spans Rx, OTC, and animal health businesses.

Arno graduated from the University of Applied Sciences in Eisenstadt, Austria and holds a master of science degree in information management.